About

Publications While At HealthPartners

selected publications

Journal Article

Phase 2 trial of nivolumab and ramucirumab for relapsed mesothelioma: HCRN-LUN15-299. 

JTO Clin Res Rep. 2023

Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. 

New England Journal of Medicine. 2018

Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. 

New England Journal of Medicine. 2017

Contact

full name

A. Chiappori

Quick Info

 

Collaboration

Co-author network

Map of science